CURALEAF AND AURORA – SOLIDIFYING THE GLOBAL CANNABIS INDUSTRY LEADER
Curaleaf Holding’s proposed combination with Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) would result in significant strategic and financial advantages through:
- Expanding a further scaled, diversified, market-leading global cannabis platform
- Maintaining superior and complementary EU-GMP manufacturing and distribution capabilities
- Accelerating growth in the most attractive international medical markets
- Driving stronger profitability through margin accretion and operational synergies
- Providing shareholders with enhanced liquidity and access to global capital markets
Immediate value for Aurora shareholders today. A stronger path forward and continued upside tomorrow.
- Aurora shareholders would receive US$4.00 per share – representing a 45% premium to Aurora’s 30-day Volume Weighted Average Price – comprised of 0.3463 Curaleaf Shares plus US$0.75 cash for each Aurora Share.
- By gaining immediate exposure to the U.S., the world's largest cannabis market, Aurora shareholders would benefit from participation in the industry's most meaningful growth opportunities and regulatory catalysts.
Relevant Documents
- Press Release (opens in a new tab)
- Letters sent to Aurora Executive Chairman
Contacts
Shareholder
Carson Proxy Advisors
North American Toll Free Phone: 1-800-530-5189
Local and text: 416-751-2066
Email: info@carsonproxy.com
Media
Kekst CNC
Kekst-Curaleaf@kekstcnc.com